2m 2m 2m 2m 2m 2m 2m
X4 PHARMA (XFOR)
NASDAQ
$2.85+$0.02 (+0.81%)
Price as of Oct 02, 2026 7:30 PM EDT- $280.6MMarket Cap
- -18.68%1-Year Change
- BiotechnologyIndustry
X4 PHARMA (XFOR)
$2.85+$0.02 (+0.81%)
XFOR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.83 | ||
Change | -$0.07 (-2.41%) | ||
Open | $2.89 | ||
High | $2.95 | ||
Low | $2.82 | ||
Previous Close | $2.90 | ||
Volume | 501,492 | ||
30-Day Average Volume | 1,193,884 | ||
1-Week Change | -5.67% | ||
1-Month Change | -30.47% | ||
1-Year Change | -18.68% | ||
3-Year Change | -91.35% | ||
5-Year Change | -98.17% | ||
Fundamentals | |||
Shares Outstanding | 99.1M | ||
Total Assets | $253.1M | ||
Market Cap | $280.6M | ||
Enterprise Value | $160.5M | ||
Period: QTR TTM FY | |||
Revenue | $6.4M | ||
Net Income | -$16.2M | ||
Free Cash Flow | -$20.8M | ||
EBIT | -$14.0M | ||
EBITDA | -$13.0M | ||
Net Working Capital | $199.5M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 25 | ||
P/B | 2 | ||
P/E | -22 | ||
PEG | -1 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 04/28/2025 | ||
Earnings & Revenue